logo
  • Global Challenge
  • Our Approach
  • Partnering
  • Pipeline
  • Join Us
  • News & Events
  • Investors
    • Company Information
    • Board and Management
    • Advisors
    • Investor Alert
  • Publications
  • Contact

World Antibiotic Awareness Week Video

November 18, 2019
|In Alderley Park, News, Publications
|By Carl Curran

 

 

  • Prev
  • All Stories
  • Next

Related News

RESP-X successfully completes Phase I trial and initiates Phase IIa trial in NCFB patients

No adverse events reported across all cohorts

Press Releases,Breaking News,Pipeline

Approval for dosing final RESP-X Phase Ia cohort and first-in-patient Phase IIa

RESP-X continues to exhibit strong safety and tolerability profile

Press Releases,Breaking News,Pipeline

Clinical candidate nominated for COV-X programme

COV-X is a novel first-in-class small molecule oral pan-coronavirus antiviral candidate

Press Releases,Breaking News,Pipeline

Podcast: Will A ‘Netflix’ Model Solve Antibiotic Reimbursement Challenges And Spur R&D?

Infex CEO Peter Jackson discusses the state of antimicrobial resistance in the UK, and…

Breaking News,Publications

Interim results demonstrate a favourable safety and tolerability profile for RESP-X in ongoing Phase I clinical trial

Accelerates plans for Phase IIa study

Press Releases,Breaking News

Infex strengthens Board with appointment of Professor Colm Leonard as Non-Executive Director

Infex Therapeutics is pleased to announce the appointment of Professor Colm Leonard as a…

Press Releases,Breaking News

Antimicrobial discovery and drug development – RSC Podcast

How do we develop drugs like antibiotics? How long does it take for such a drug to go…

Breaking News,Publications

Infex’s novel AMR drug candidate MET-X receives FDA QIDP designation

This designation gives MET-X an accelerated U.S. regulatory pathway and an additional…

Press Releases,Breaking News,Pipeline

Infex enters clinic with lead anti-virulence candidate RESP-X for Pseudomonas aeruginosa

Infex Therapeutics, a leading anti-infectives specialist, is pleased to announce the…

Press Releases,Breaking News,Pipeline

© Infex Therapeutics Ltd. All rights reserved.